Sunday, October 12, 2025
Home Authors Posts by Ogkologos

Ogkologos

4034 POSTS 0 COMMENTS

Improved Survival Benefit with Encorafenib plus Cetuximab plus mFOLFOX6 in First-Line...

Ogkologos -
0

ESMO Gastrointestinal Cancers Congress 2025, Barcelona, Spain, 2-5 July

Ogkologos -
0

Neoadjuvant Nivolumab Plus Chemotherapy Improves OS Among Patients with Resectable NSCLC...

Ogkologos -
0

ESMO Advocates for EU Legislation to Prevent Oncologist Burnout and Ensure...

Ogkologos -
0

Adding Relacorilant To Nab-paclitaxel Prolongs Survival Compared with a Weekly Taxane...

Ogkologos -
0

FDA Approves Retifanlimab-dlwr with Carboplatin and Paclitaxel and as a Single...

Ogkologos -
0

EMA Recommends Extension of Therapeutic Indications for Acalabrutinib

Ogkologos -
0

Large DFS Benefit from Adjuvant Cemiplimab Among Patients at High Risk...

Ogkologos -
0

French Senate Committee Backs ESMO Call to Revise EU Regulation to...

Ogkologos -
0

Structured Exercise Programme Initiated Soon After the Completion of Adjuvant Chemotherapy...

Ogkologos -
0
1...101112...404Page 11 of 404

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com